161 related articles for article (PubMed ID: 11171602)
1. Regulation of cardiac and skeletal muscle malonyl-CoA decarboxylase by fatty acids.
Young ME; Goodwin GW; Ying J; Guthrie P; Wilson CR; Laws FA; Taegtmeyer H
Am J Physiol Endocrinol Metab; 2001 Mar; 280(3):E471-9. PubMed ID: 11171602
[TBL] [Abstract][Full Text] [Related]
2. Peroxisomal-proliferator-activated receptor alpha activates transcription of the rat hepatic malonyl-CoA decarboxylase gene: a key regulation of malonyl-CoA level.
Lee GY; Kim NH; Zhao ZS; Cha BS; Kim YS
Biochem J; 2004 Mar; 378(Pt 3):983-90. PubMed ID: 14641110
[TBL] [Abstract][Full Text] [Related]
3. Evidence for mitochondrial thioesterase 1 as a peroxisome proliferator-activated receptor-alpha-regulated gene in cardiac and skeletal muscle.
Stavinoha MA; RaySpellicy JW; Essop MF; Graveleau C; Abel ED; Hart-Sailors ML; Mersmann HJ; Bray MS; Young ME
Am J Physiol Endocrinol Metab; 2004 Nov; 287(5):E888-95. PubMed ID: 15292030
[TBL] [Abstract][Full Text] [Related]
4. Characterization of rat liver malonyl-CoA decarboxylase and the study of its role in regulating fatty acid metabolism.
Dyck JR; Berthiaume LG; Thomas PD; Kantor PF; Barr AJ; Barr R; Singh D; Hopkins TA; Voilley N; Prentki M; Lopaschuk GD
Biochem J; 2000 Sep; 350 Pt 2(Pt 2):599-608. PubMed ID: 10947976
[TBL] [Abstract][Full Text] [Related]
5. Tissue-specific regulation of malonyl-CoA decarboxylase activity in OLETF rats.
Kim HJ; Zhao ZS; Lee YJ; Shim WS; Kim SK; Ahn CW; Park CW; Lee HC; Cha BS
Diabetes Obes Metab; 2006 Mar; 8(2):175-83. PubMed ID: 16448521
[TBL] [Abstract][Full Text] [Related]
6. Malonyl-CoA content and fatty acid oxidation in rat muscle and liver in vivo.
Chien D; Dean D; Saha AK; Flatt JP; Ruderman NB
Am J Physiol Endocrinol Metab; 2000 Aug; 279(2):E259-65. PubMed ID: 10913024
[TBL] [Abstract][Full Text] [Related]
7. Regulation of fatty acid oxidation and glucose metabolism in rat soleus muscle: effects of AICAR.
Kaushik VK; Young ME; Dean DJ; Kurowski TG; Saha AK; Ruderman NB
Am J Physiol Endocrinol Metab; 2001 Aug; 281(2):E335-40. PubMed ID: 11440910
[TBL] [Abstract][Full Text] [Related]
8. Uncoupling protein 3 transcription is regulated by peroxisome proliferator-activated receptor (alpha) in the adult rodent heart.
Young ME; Patil S; Ying J; Depre C; Ahuja HS; Shipley GL; Stepkowski SM; Davies PJ; Taegtmeyer H
FASEB J; 2001 Mar; 15(3):833-45. PubMed ID: 11259402
[TBL] [Abstract][Full Text] [Related]
9. Diurnal variations in the responsiveness of cardiac and skeletal muscle to fatty acids.
Stavinoha MA; Rayspellicy JW; Hart-Sailors ML; Mersmann HJ; Bray MS; Young ME
Am J Physiol Endocrinol Metab; 2004 Nov; 287(5):E878-87. PubMed ID: 15292029
[TBL] [Abstract][Full Text] [Related]
10. MCD encodes peroxisomal and cytoplasmic forms of malonyl-CoA decarboxylase and is mutated in malonyl-CoA decarboxylase deficiency.
Sacksteder KA; Morrell JC; Wanders RJ; Matalon R; Gould SJ
J Biol Chem; 1999 Aug; 274(35):24461-8. PubMed ID: 10455107
[TBL] [Abstract][Full Text] [Related]
11. A role for peroxisome proliferator-activated receptor alpha (PPARalpha ) in the control of cardiac malonyl-CoA levels: reduced fatty acid oxidation rates and increased glucose oxidation rates in the hearts of mice lacking PPARalpha are associated with higher concentrations of malonyl-CoA and reduced expression of malonyl-CoA decarboxylase.
Campbell FM; Kozak R; Wagner A; Altarejos JY; Dyck JR; Belke DD; Severson DL; Kelly DP; Lopaschuk GD
J Biol Chem; 2002 Feb; 277(6):4098-103. PubMed ID: 11734553
[TBL] [Abstract][Full Text] [Related]
12. Troglitazone downregulates delta-6 desaturase gene expression in human skeletal muscle cell cultures.
Wahl HG; Kausch C; Machicao F; Rett K; Stumvoll M; Häring HU
Diabetes; 2002 Apr; 51(4):1060-5. PubMed ID: 11916926
[TBL] [Abstract][Full Text] [Related]
13. Characterization of cardiac malonyl-CoA decarboxylase and its putative role in regulating fatty acid oxidation.
Dyck JR; Barr AJ; Barr RL; Kolattukudy PE; Lopaschuk GD
Am J Physiol; 1998 Dec; 275(6):H2122-9. PubMed ID: 9843812
[TBL] [Abstract][Full Text] [Related]
14. Contribution of malonyl-CoA decarboxylase to the high fatty acid oxidation rates seen in the diabetic heart.
Sakamoto J; Barr RL; Kavanagh KM; Lopaschuk GD
Am J Physiol Heart Circ Physiol; 2000 Apr; 278(4):H1196-204. PubMed ID: 10749714
[TBL] [Abstract][Full Text] [Related]
15. Activation of malonyl-CoA decarboxylase in rat skeletal muscle by contraction and the AMP-activated protein kinase activator 5-aminoimidazole-4-carboxamide-1-beta -D-ribofuranoside.
Saha AK; Schwarsin AJ; Roduit R; Masse F; Kaushik V; Tornheim K; Prentki M; Ruderman NB
J Biol Chem; 2000 Aug; 275(32):24279-83. PubMed ID: 10854420
[TBL] [Abstract][Full Text] [Related]
16. Malonyl coenzyme a decarboxylase inhibition protects the ischemic heart by inhibiting fatty acid oxidation and stimulating glucose oxidation.
Dyck JR; Cheng JF; Stanley WC; Barr R; Chandler MP; Brown S; Wallace D; Arrhenius T; Harmon C; Yang G; Nadzan AM; Lopaschuk GD
Circ Res; 2004 May; 94(9):e78-84. PubMed ID: 15105298
[TBL] [Abstract][Full Text] [Related]
17. Malonyl CoenzymeA decarboxylase regulates lipid and glucose metabolism in human skeletal muscle.
Bouzakri K; Austin R; Rune A; Lassman ME; Garcia-Roves PM; Berger JP; Krook A; Chibalin AV; Zhang BB; Zierath JR
Diabetes; 2008 Jun; 57(6):1508-16. PubMed ID: 18314420
[TBL] [Abstract][Full Text] [Related]
18. Troglitazone effects on gene expression in human skeletal muscle of type II diabetes involve up-regulation of peroxisome proliferator-activated receptor-gamma.
Park KS; Ciaraldi TP; Lindgren K; Abrams-Carter L; Mudaliar S; Nikoulina SE; Tufari SR; Veerkamp JH; Vidal-Puig A; Henry RR
J Clin Endocrinol Metab; 1998 Aug; 83(8):2830-5. PubMed ID: 9709955
[TBL] [Abstract][Full Text] [Related]
19. Peroxisome proliferator-activated receptor-alpha regulates fatty acid utilization in primary human skeletal muscle cells.
Muoio DM; Way JM; Tanner CJ; Winegar DA; Kliewer SA; Houmard JA; Kraus WE; Dohm GL
Diabetes; 2002 Apr; 51(4):901-9. PubMed ID: 11916905
[TBL] [Abstract][Full Text] [Related]
20. Impaired expression of the uncoupling protein-3 gene in skeletal muscle during lactation: fibrates and troglitazone reverse lactation-induced downregulation of the uncoupling protein-3 gene.
Pedraza N; Solanes G; Carmona MC; Iglesias R; Viñas O; Mampel T; Vazquez M; Giralt M; Villarroya F
Diabetes; 2000 Jul; 49(7):1224-30. PubMed ID: 10909982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
